Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Carmen Schade-Brittinger Nicoletta Colombo Domenica Lorusso Frederik Marmé Ignace Vergote Christian Marth |
| Publication date | June 6, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |